Class information for:
Level 2: RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
389 16325 36.2 77%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
384 29024 RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL

Classes in level below (level 1)


ID, lev. below Publications Label for level below
252 3731 ABATACEPT//TOCILIZUMAB//DISEASE MODIFYING ANTIRHEUMATIC DRUGS
3580 1877 METHOTREXATE//METHOTREXATE POLYGLUTAMATES//MX 68
4327 1730 CITRULLINATION//PEPTIDYLARGININE DEIMINASE//ANTIPERINUCLEAR FACTOR
4580 1689 ANTI TNF ALPHA ANTIBODY INFLIXIMAB//EPIDEMIOL COMPUTAT BIOL//RHEUMATOID CACHEXIA
5042 1615 SYNOVITIS//CLIN REUMATOL//ENTHESITIS
7113 1328 PTPN22//PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22//IRF5
10406 1000 SHARED EPITOPE//HLA DRB1//HLA DR4
13342 779 COPCORD//RHEUMATIC MUSCULOSKELETAL DISORDERS//COMMUNITY BASED EPIDEMIOL PREVENT TREATMENT RHE
13641 759 DISSOLUCYTOSIS//METALLIC GOLD//AURANOFIN
18469 485 JOINT SPACE MEASUREMENT//COMPUTER AIDED JOINT SPACE ANALYSIS//SHARP SCORE
19029 458 SULFASALAZINE//SULPHASALAZINE//2ND LINE AGENT
23191 300 ANTI TNF ALPHA THERAPIES//GENHOTEL RECH EUROPEEN POLYARTHRITE RHUMATOID//PATHOL RHEUMATOL
25003 245 RS3PE//REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA//RS3PE SYNDROME
30444 138 AG LES MARKUS KRANKENHAUS//DESERT ORTHOPED//DISEASE MODIFYING ANTI RHEUMATIC DRUGS DMARD
31449 123 TENIDAP//TEPOXALIN//TENIDAP SODIUM
34542 68 PALINDROMIC RHEUMATISM//RECURRENT ARTHRITIS//INTERMITTENT HYDRARTHROSIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 RHEUMATOID ARTHRITIS Author keyword 1599 27% 31% 5024
2 RHEUMATOLOGY WoS category 1067 10% 59% 9629
3 RHEUMATOL Address 543 12% 26% 4215
4 ANNALS OF THE RHEUMATIC DISEASES Journal 271 17% 9% 1445
5 JOURNAL OF RHEUMATOLOGY Journal 201 12% 9% 1516
6 CITRULLINATION Author keyword 167 80% 1% 104
7 EARLY RHEUMATOID ARTHRITIS Author keyword 164 64% 1% 161
8 METHOTREXATE Author keyword 157 17% 5% 849
9 PTPN22 Author keyword 134 72% 1% 106
10 RHEUMATOID FACTOR Author keyword 125 38% 2% 259

Web of Science journal categories


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 Rheumatology 1067 10% 59% 9629

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 RHEUMATOID ARTHRITIS 1599 27% 31% 5024 Search RHEUMATOID+ARTHRITIS Search RHEUMATOID+ARTHRITIS
2 CITRULLINATION 167 80% 1% 104 Search CITRULLINATION Search CITRULLINATION
3 EARLY RHEUMATOID ARTHRITIS 164 64% 1% 161 Search EARLY+RHEUMATOID+ARTHRITIS Search EARLY+RHEUMATOID+ARTHRITIS
4 METHOTREXATE 157 17% 5% 849 Search METHOTREXATE Search METHOTREXATE
5 PTPN22 134 72% 1% 106 Search PTPN22 Search PTPN22
6 RHEUMATOID FACTOR 125 38% 2% 259 Search RHEUMATOID+FACTOR Search RHEUMATOID+FACTOR
7 ANTI CCP 118 83% 0% 67 Search ANTI+CCP Search ANTI+CCP
8 SHARED EPITOPE 111 77% 0% 76 Search SHARED+EPITOPE Search SHARED+EPITOPE
9 ANTI CCP ANTIBODIES 111 86% 0% 56 Search ANTI+CCP+ANTIBODIES Search ANTI+CCP+ANTIBODIES
10 PEPTIDYLARGININE DEIMINASE 105 80% 0% 66 Search PEPTIDYLARGININE+DEIMINASE Search PEPTIDYLARGININE+DEIMINASE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MODIFYING ANTIRHEUMATIC DRUGS 942 66% 5% 871
2 CYCLIC CITRULLINATED PEPTIDE 427 69% 2% 368
3 ANTIKERATIN ANTIBODIES 326 87% 1% 160
4 FINGER JOINTS 307 66% 2% 284
5 ANTIFILAGGRIN AUTOANTIBODIES 280 86% 1% 142
6 PLUS METHOTREXATE 278 79% 1% 179
7 ANTIPERINUCLEAR FACTOR 260 85% 1% 135
8 ANTITUMOR NECROSIS FACTOR 246 46% 2% 399
9 LOW DOSE METHOTREXATE 241 38% 3% 506
10 EARLY RHEUMATOID ARTHRITIS 239 39% 3% 481

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 ANNALS OF THE RHEUMATIC DISEASES 271 17% 9% 1445
2 JOURNAL OF RHEUMATOLOGY 201 12% 9% 1516
3 RHEUMATOLOGY 94 14% 4% 615
4 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 90 13% 4% 651
5 ARTHRITIS RESEARCH & THERAPY 63 14% 3% 409
6 SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 48 13% 2% 357
7 MODERN RHEUMATOLOGY 40 19% 1% 193
8 ZEITSCHRIFT FUR RHEUMATOLOGIE 38 13% 2% 279
9 ARTHRITIS CARE & RESEARCH 33 15% 1% 207
10 BRITISH JOURNAL OF RHEUMATOLOGY 32 12% 2% 257

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update 2014 178 125 83%
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs 2010 616 106 89%
Treating rheumatoid arthritis to target: recommendations of an international task force 2010 523 64 75%
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis 2010 406 97 81%
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis 2011 497 97 44%
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis 2015 8 61 61%
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis 2008 592 213 68%
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges 2015 5 132 77%
Rheumatoid arthritis 2009 299 122 79%
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials 2006 1151 54 41%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 RHEUMATOL 543 12% 26% 4215
2 RHEUMATOL UNIT 96 15% 3.7% 598
3 SECT MUSCULOSKELETAL DIS 44 40% 0.5% 86
4 RHEUMATOL CLIN IMMUNOL 43 13% 1.9% 313
5 NIHR LEEDS MUSCULOSKELETAL BIOMED UNIT 42 40% 0.5% 83
6 CLIN REUMATOL 41 48% 0.4% 62
7 ARTHRIT UK EPIDEMIOL UNIT 38 32% 0.6% 98
8 UNIT MUSCULOSKELETAL DIS 37 37% 0.5% 82
9 BIOACT REGULAT 32 88% 0.1% 15
10 CATTEDRA REUMATOL 32 37% 0.4% 68

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000037253 ARTHRITIS CARE AND RESEARCH//ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH//HEALTH ASSESSMENT QUESTIONNAIRE
2 0.0000018037 COLLAGEN INDUCED ARTHRITIS//SECT MED INFLAMMAT//INTERLEUKIN 1 RECEPTOR ANTAGONIST
3 0.0000014307 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS//JUVENILE IDIOPATHIC ARTHRITIS//ADULT ONSET STILLS DISEASE
4 0.0000013782 LEFLUNOMIDE//LINOMIDE//MIZORIBINE
5 0.0000012372 PSORIASIS//PSORIATIC ARTHRITIS//CALCIPOTRIOL
6 0.0000011789 ANKYLOSING SPONDYLITIS//HLA B27//SPONDYLOARTHRITIS
7 0.0000010802 RAMADAN//RAMADAN FASTING//ISLAMIC FASTING
8 0.0000008124 SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//LUPUS NEPHRITIS
9 0.0000007725 MUSCULOSKELETAL EXAMINATION//AMBULATORY NEUROLOGICAL CARE//NEUROLOGICAL CARE
10 0.0000006423 INTERLEUKIN 10//IL 1RN//INTERLEUKIN 1 BETA GENE